Evaluation of HEArt invoLvement in Patients With FABRY Disease

NCT03362164 · tracked via the Priya Life Science Germany tracker

Sponsor

Wuerzburg University Hospital

Phase

Observational

Started

2001-01

Last updated

2022-07-07

Condition(s) studied

Rare DiseasesFabry DiseaseFabry Disease, Cardiac VariantHypertrophic Cardiomyopathy

Study summary

This study evaluates predictors for the incidence of arrhythmias and sudden cardiac death as well as terminal heart failure in patients with Fabry disease.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Fabry disease (genetically confirmed) * Signed informed consent * 18 years and older Exclusion Criteria: * No informed consent * Withdrawal of informed consent

Primary outcome measure(s)

Cardiac death — From date of inclusion until the date of first documented event, up to the year 2032
Patients sustaining cardiac death

Trial sites (1)

Facility	City	Region	Status
Wuerzburg University Hospital	Würzburg	Bavaria	Recruiting

More Wuerzburg University Hospital trials in Germany

Lymphatic Organs and Myocardium After Myocardial Infarction Recruiting

Burden of Disease and Functional Impairment in XLH Active, not recruiting

Exploratory Investigation of the Acceptance and Utility of 14-day Trial Periods and Application-related Outcome Measurement (AbEM) Within the Routine Prescription of the DiGA Axia. Recruiting

Radiotherapy of Head and Neck Cancer With SIB Recruiting

PSMA in Gastroenterologic Tumors (GIPSMA) Recruiting

Other trials for the same condition

HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy Active, not recruiting

Fabry Disease Registry & Pregnancy Sub-registry Recruiting

A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants Recruiting

Genetic Causes of Discrepant Clinic in Monogenic Twins Recruiting

Characterizing the Retinal Microvasculature in Patients with Fabry Disease: a Prospective Observational Study Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03362164 on ClinicalTrials.gov ↗ ← All trials in Germany